These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3783175)

  • 21. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine coadministration with fluoxetine or fluvoxamine.
    Spina E; Avenoso A; Pollicino AM; Caputi AP; Fazio A; Pisani F
    Ther Drug Monit; 1993 Jun; 15(3):247-50. PubMed ID: 8333006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs.
    Kacirova I; Grundmann M; Brozmanova H
    Epilepsy Res; 2016 May; 122():84-90. PubMed ID: 26991491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
    Leinonen E; Lepola U; Koponen H
    Pharmacopsychiatry; 1996 Jul; 29(4):156-8. PubMed ID: 8858715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical pharmacokinetics of viloxazine chlorhydrate. Practical implications].
    Bouquet S; Vandel B; Guibert S; Lavoisy J
    Encephale; 1989; 15(5):443-7. PubMed ID: 2686964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentre study with viloxazine (Vivalan) in depressed patients.
    Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
    Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
    [No Abstract]   [Full Text] [Related]  

  • 29. Relationship between blood and cerebrospinal levels of the antidepressant agent viloxazine.
    Elwan O; Adam HK
    Eur J Clin Pharmacol; 1980; 17(3):179-82. PubMed ID: 7363931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of josamycin on carbamazepine kinetics.
    Vinçon G; Albin H; Demotes-Mainard F; Guyot M; Bistue C; Loiseau P
    Eur J Clin Pharmacol; 1987; 32(3):321-3. PubMed ID: 3595706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetic study of conventional and sustained-release viloxazine in normal volunteers.
    Kergueris MF; Bourin M; Ribeyrol M; Beneroso N; Normand YL; Larousse C
    Neuropsychobiology; 1989; 20(3):136-40. PubMed ID: 2761683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term tolerance of viloxazine].
    Brion S; Chevalier JF
    Encephale; 1982; 8(4):511-21. PubMed ID: 7151740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma.
    McKauge L; Tyrer JH; Eadie MJ
    Ther Drug Monit; 1981; 3(1):63-70. PubMed ID: 7233491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.
    Magnus RV
    J Int Med Res; 1975; 3(3):207-13. PubMed ID: 162677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: interactions with reserpine.
    Cuomo V; Cagiano R; Brunello N; Fumagalli R; Racagni G
    Neurosci Lett; 1983 Oct; 40(3):315 -9. PubMed ID: 6646506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
    Kodama Y; Kuranari M; Tsutsumi K; Okamoto T; Kodama H; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):618-21. PubMed ID: 7874378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
    Zielinski JJ; Haidukewych D; Leheta BJ
    Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.
    Gillham RA; Williams N; Wiedmann K; Butler E; Larkin JG; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):929-33. PubMed ID: 3204401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.